| Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity. | |
| | |
MedLine Citation:
|
PMID: 19335423 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Lipoprotein (a) [Lp(a)] is a genetically determined molecule whose role has been implied in cardiovascular pathology, and whose levels have been reported to be elevated in patients with psoriasis. Aim To assess the serum levels of Lp(a) in patients with psoriasis, and to investigate the associations of Lp(a) with other lipids and with psoriasis severity. METHODS: Thirty-four patients with psoriasis and 26 healthy control subjects took part in the study. Serum levels of Lp(a) and total, high density lipoprotein (HDL), low density lipoprotein (LDL), and very low density lipoprotein (VLDL) cholesterol fractions were measured in all participants. The levels of triglycerides and total cholesterol were measured using enzymatic colorimetric tests; HDL and LDL cholesterol concentrations were determined by precipitation methods; the VLDL concentration was calculated according to the formula: VLDL cholesterol = triglycerides/5. RESULTS: Patients with psoriasis showed significantly higher serum levels of Lp(a) relative to controls. Even when controlling for normolipidemic vs. hyperlipidemic status, abnormal levels of Lp(a) (> 30 mg/dL) were observed significantly more often in patients than in controls. In both patients and controls, Lp(a) levels correlated positively with total and HDL cholesterol levels. In patients, Lp(a) levels correlated positively with psoriasis severity. CONCLUSIONS: Lp(a) may be a factor contributing to an increased cardiovascular risk in patients with psoriasis. A pathogenetic link may exist between this lipoprotein and psoriatic pathophysiology. |
| | |
Authors:
|
Aldona Pietrzak; Jacek Kadzielewski; Konrad Janowski; Jacek Roliński; Dorota Krasowska; Grazyna Chodorowska; Tomasz Paszkowski; Ewa Kapeć; Iwona Jastrzebska; Jacek Tabarkiewicz; Torello Lotti |
Related Documents
:
|
2884853 - Plasma lipid lowering effects of doxazosin, a new selective alpha1 adrenergic inhibitor... 1830853 - Lp(a) lipoprotein in patients with arterial insufficiency of the lower extremities. 11421333 - The effects of dietary l-carnitine supplementation on the performance, organ weights an... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: International journal of dermatology Volume: 48 ISSN: 1365-4632 ISO Abbreviation: Int. J. Dermatol. Publication Date: 2009 Apr |
Date Detail:
|
Created Date: 2009-04-01 Completed Date: 2009-07-13 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0243704 Medline TA: Int J Dermatol Country: United States |
Other Details:
|
Languages: eng Pagination: 379-87 Citation Subset: IM |
Affiliation:
|
Department of Dermatology, Medical University of Lublin, Lublin, Poland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Cardiovascular Diseases / epidemiology Cholesterol, HDL / blood Cholesterol, LDL / blood Cholesterol, VLDL / blood Humans Hyperlipidemias / blood, epidemiology Lipids / blood* Lipoprotein(a) / blood* Male Middle Aged Psoriasis / blood*, epidemiology* Risk Factors Severity of Illness Index* Triglycerides / blood Young Adult |
| Chemical | |
Reg. No./Substance:
|
0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Cholesterol, VLDL; 0/Lipids; 0/Lipoprotein(a); 0/Triglycerides |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Severity of disease, rather than xerosis, correlates with pruritus in patients with atopic dermatiti...
Next Document: A novel missense mutation in the SLC6A19 gene in a Chinese family with Hartnup disorder.